J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
NJBIZ10 天
J&J’s ketamine-based drug approved as standalone treatment
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
New York Post11 天
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering ... FDA priority review, comes after more than ...
fox6now11 天
FDA approves first-of-its-kind nasal spray to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering ... following FDA priority review, comes after more ...
Medical Xpress11 天
FDA approves nasal spray for treatment-resistant depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ... Approval ...
Fast Company11 天
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ ...
Spravato, which is derived from ketamine ... patients need to be treated in a doctor’s office or hospital setting and remain in the clinic until the side effects have passed. The nasal spray ...
The Straits Times11 天
Controlled drug Ketamine a lifeline for patients with severe depression in S’pore
SINGAPORE – Ketamine ... depressed patients in Singapore. Since October 2020 – when the Health Sciences Authority first authorised the sale of an esketamine nasal spray for serious depression ...